Literature DB >> 20299544

Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study.

G Zuliani1, M Cavalieri, M Galvani, S Volpato, A Cherubini, S Bandinelli, A M Corsi, F Lauretani, J M Guralnik, R Fellin, L Ferrucci.   

Abstract

BACKGROUND: To evaluate the association between plasma lipid fractions and the prevalence of dementia in a large sample of Italian older individuals.
METHODS: A total of 1051 older community-dwelling individuals (age >/=65 years), enrolled in the InChianti study, were included. Diagnosis of dementia was established at baseline and at the 3-year follow-up using Diagnostic and Statistical Manual of Mental Disorder (Fourth Edition) criteria. Plasma lipids were measured by standardized methods at baseline and after 3 years.
RESULTS: At baseline, 61 individuals (5.8%) were affected by dementia. Demented individuals showed significantly lower total cholesterol (TC), nonhigh-density lipoprotein cholesterol, and high-density lipoprotein cholesterol (HDL-C) levels compared with controls; no differences were found in triglycerides (TG) and lipoprotein (a) levels. Of the 819 subjects reevaluated at the 3-year follow-up, 81 (9.9%) received a new diagnosis of dementia. Again, demented subjects were characterized by significantly lower TC, non-HDL-C, and HDL-C levels compared with controls, thus confirming the baseline findings. At multivariate logistic regression analysis, HDL-C levels (odds ratio: 0.96, 95% confidence interval: 0.93-0.99), but not TG and non-HDL-C, were associated with dementia independent of important confounders including age, gender, apo E phenotype, stroke, weight loss, interleukin 6 levels, and ankle-brachial index.
CONCLUSIONS: Among community-dwelling older people, individuals affected by dementia showed significantly lower TC, non-HDL-C, and HDL-C levels; however, at multivariate analysis, only HDL-C was associated with dementia. Our results suggest the existence of an independent relationship between dementia and low HDL-C levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299544      PMCID: PMC2854885          DOI: 10.1093/gerona/glq026

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  40 in total

1.  Lipid metabolism parameters in patients with Alzheimer's disease and their first degree relatives.

Authors:  K Czyzewski; M M Lalowski; A Pfeffer; M Barcikowska
Journal:  Acta Neurobiol Exp (Wars)       Date:  2001       Impact factor: 1.579

2.  High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study.

Authors:  Giovanni Zuliani; Stefano Volpato; Alessando Blè; Stefania Bandinelli; Anna Maria Corsi; Fulvio Lauretani; Giuseppe Paolisso; Renato Fellin; Luigi Ferrucci
Journal:  Atherosclerosis       Date:  2006-06-19       Impact factor: 5.162

3.  Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.

Authors:  I L Notkola; R Sulkava; J Pekkanen; T Erkinjuntti; C Ehnholm; P Kivinen; J Tuomilehto; A Nissinen
Journal:  Neuroepidemiology       Date:  1998       Impact factor: 3.282

4.  Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group.

Authors:  G Siest; P Bertrand; B Qin; B Herbeth; J M Serot; L Masana; J Ribalta; A P Passmore; A Evans; M Ferrari; M Franceschi; J Shepherd; M Cuchel; U Beisiegel; K Zuchowsky; A S Rukavina; J Sertic; M Stojanov; V Kostic; A Mitrevski; V Petrova; C Sass; A Merched; J T Salonen; L Tiret; S Visvikis
Journal:  Clin Chem Lab Med       Date:  2000-08       Impact factor: 3.694

5.  Cholesterol and neuropathologic markers of AD: a population-based autopsy study.

Authors:  L J Launer; L R White; H Petrovitch; G W Ross; J D Curb
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

6.  Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.

Authors:  A Solomon; I Kåreholt; T Ngandu; B Winblad; A Nissinen; J Tuomilehto; H Soininen; M Kivipelto
Journal:  Neurology       Date:  2007-03-06       Impact factor: 9.910

7.  The relation between apolipoprotein A-I and dementia: the Honolulu-Asia aging study.

Authors:  Jane S Saczynski; Lon White; Rita L Peila; Beatriz L Rodriguez; Lenore J Launer
Journal:  Am J Epidemiol       Date:  2007-02-13       Impact factor: 4.897

8.  High total cholesterol levels in late life associated with a reduced risk of dementia.

Authors:  M M Mielke; P P Zandi; M Sjögren; D Gustafson; S Ostling; B Steen; I Skoog
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

9.  Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study.

Authors:  J Kuusisto; K Koivisto; L Mykkänen; E L Helkala; M Vanhanen; T Hänninen; K Kervinen; Y A Kesäniemi; P J Riekkinen; M Laakso
Journal:  BMJ       Date:  1997-10-25

10.  Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Authors:  Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Peter W F Wilson; Douglas P Kiel; Michael Tocco; Ralph B D'Agostino; Philip A Wolf
Journal:  Arch Intern Med       Date:  2003-05-12
View more
  27 in total

1.  Rates and risk factors for progression to incident dementia vary by age in a population cohort.

Authors:  Mary Ganguli; Ching-Wen Lee; Beth E Snitz; Tiffany F Hughes; Eric McDade; Chung-Chou H Chang
Journal:  Neurology       Date:  2014-12-03       Impact factor: 9.910

2.  Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women : A 10-year follow-up.

Authors:  Matej Bendzala; Peter Sabaka; Martin Caprnda; Andrea Komornikova; Maria Bisahova; Ruth Baneszova; Daniel Petrovic; Robert Prosecky; Luis Rodrigo; Peter Kruzliak; Andrej Dukat
Journal:  Wien Klin Wochenschr       Date:  2017-09-14       Impact factor: 1.704

Review 3.  Devising a new dialogue for nutrition science: how life course perspective, U-shaped thinking, whole organism thinking, and language precision contribute to our understanding of biological heterogeneity and forge a fresh advance toward precision medicine.

Authors:  David J Waters
Journal:  J Anim Sci       Date:  2020-03-01       Impact factor: 3.159

Review 4.  Potential of Glucagon-Like Peptide 1 as a Regulator of Impaired Cholesterol Metabolism in the Brain.

Authors:  Young-Kook Kim; Juhyun Song
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

5.  Serum high-density lipoprotein cholesterol levels correlate well with functional but not with cognitive status in 85-year-old subjects.

Authors:  F Formiga; A Ferrer; D Chivite; X Pinto; T Badia; G Padrós; R Pujol
Journal:  J Nutr Health Aging       Date:  2012-05       Impact factor: 4.075

Review 6.  HDL and cognition in neurodegenerative disorders.

Authors:  David A Hottman; Dustin Chernick; Shaowu Cheng; Zhe Wang; Ling Li
Journal:  Neurobiol Dis       Date:  2014-08-13       Impact factor: 5.996

Review 7.  The Role of High-Density Lipoprotein in Lowering Risk of Dementia in the Elderly: A Review.

Authors:  Supraja N Avula; Ke-Li-Ta N Joseph; Chibuzor V Onuchukwu; Vishwanath Thondamala; Shashwat Shrivastava; Anusha R Namburi; Lubna Mohammed
Journal:  Cureus       Date:  2022-04-22

8.  Cortisol, HDL-c, VLDL-c, and APOE Polymorphisms as Laboratorial Parameters Associated to Cognitive Impairment No Dementia (CIND) and Dementia.

Authors:  Vivian P Lara; Paulo Caramelli; Antônio L Teixeira; Maira T Barbosa; Karoline C Carmona; Henrique C Guimarães; Maria G Carvalho; Ana P Fernandes; Karina B Gomes
Journal:  J Clin Lab Anal       Date:  2015-08-24       Impact factor: 2.352

9.  Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender.

Authors:  James R Hall; April R Wiechmann; Leigh A Johnson; Melissa Edwards; Robert C Barber; Rebecca Cunningham; Meharvan Singh; Sid E O'Bryant
Journal:  Dement Geriatr Cogn Disord       Date:  2014-07-04       Impact factor: 2.959

10.  Plasma levels of HDL and carotenoids are lower in dementia patients with vascular comorbidities.

Authors:  Irundika H K Dias; Maria Cristina Polidori; Li Li; Daniela Weber; Wilhelm Stahl; Gereon Nelles; Tilman Grune; Helen R Griffiths
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.